ARL4C
ADP-ribosylation factor-like protein 4C
Also known as: ARL4C_HUMAN, ARL7, LAK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56559
- Gene
- ARL4C
- Ensembl
- ENSG00000188042
- Chromosome
- 2
- Canonical length
- 192 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
ADP-ribosylation factor-like 4C is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4C is closely similar to ARL4A and ARL4D and each has a nuclear localization signal and an unusually high guanine nucleotide exchange rate. This protein may play a role in cholesterol transport. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
192 residues, UniProt reviewed canonical sequence.
>P56559|ARL4C
1 MGNISSNISA FQSLHIVMLG LDSAGKTTVL YRLKFNEFVN TVPTIGFNTE KIKLSNGTAK
61 GISCHFWDVG GQEKLRPLWK SYSRCTDGII YVVDSVDVDR LEEAKTELHK VTKFAENQGT
121 PLLVIANKQD LPKSLPVAEI EKQLALHELI PATTYHVQPA CAIIGEGLTE GMDKLYEMIL
181 KRRKSLKQKK KRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARL4C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- thymus: 69 nTPM
- bone marrow: 61 nTPM
- lymph node: 52 nTPM
- spleen: 48 nTPM
- choroid plexus: 40 nTPM
- tonsil: 30 nTPM
Single-cell type
- nk-cells: 440 nCPM
- kupffer cells: 423 nCPM
- t-cells: 324 nCPM
- pdcs: 323 nCPM
- cdc: 309 nCPM
- macrophages: 272 nCPM
Immune cell
- gdT-cell: 87 nTPM
- MAIT T-cell: 86 nTPM
- T-reg: 84 nTPM
- basophil: 80 nTPM
- memory CD8 T-cell: 70 nTPM
- NK-cell: 61 nTPM
Brain region
- choroid plexus: 96 nTPM
- hypothalamus: 45 nTPM
- pons: 44 nTPM
- thalamus: 37 nTPM
- cerebral cortex: 37 nTPM
- cerebellum: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.76
- gnomAD missense Z
- 2.45
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARL4C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARL4C as an antibody target. Whether an autoantibody or antibody against ARL4C could matter depends on whether native ARL4C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARL4C is annotated at the cell surface, where native ARL4C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ARL4C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...